Unraveling the phenotypic states of human innate-like T cells: Comparative insights with conventional T cells and mouse models

被引:1
作者
Loh, Liyen [1 ]
Carcy, Salome [2 ,3 ]
Krovi, Harsha S. [4 ]
Domenico, Joanne [1 ]
Spengler, Andrea [1 ]
Lin, Yong [3 ]
Torres, Joshua [3 ]
Prabakar, Rishvanth K. [3 ]
Palmer, William [1 ]
Norman, Paul J. [1 ]
Stone, Matthew [5 ]
Brunetti, Tonya [1 ]
Meyer, Hannah V. [3 ]
Gapin, Laurent [1 ]
机构
[1] Univ Colorado Anschutz Med Campus, Aurora, CO 80045 USA
[2] Cold Spring Harbor Lab, Sch Biol Sci, Cold Spring Harbor, NY USA
[3] Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, Cold Spring Harbor, NY 11724 USA
[4] Brigham & Womens Hosp, Boston, MA USA
[5] Childrens Hosp Colorado, Aurora, CO USA
来源
CELL REPORTS | 2024年 / 43卷 / 09期
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
GAMMA-DELTA T; RNA-SEQUENCING DATA; MAIT CELLS; REGULATORY NETWORK; NKT; EFFECTOR; SUBSETS; ACTIVATION; THYMUS; INKT;
D O I
10.1016/j.celrep.2024.114705
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The "innate-like" T cell compartment, known as T-inn, represents a diverse group of T cells that straddle the boundary between innate and adaptive immunity. We explore the transcriptional landscape of T-inn compared to conventional T cells (T-conv) in the human thymus and blood using single-cell RNA sequencing (scRNA-seq) and flow cytometry. In human blood, the majority of T-inn cells share an effector program driven by specific transcription factors, distinct from those governing T-conv cells. Conversely, only a fraction of thymic T-inn cells displays an effector phenotype, while others share transcriptional features with developing T-conv cells, indicating potential divergent developmental pathways. Unlike the mouse, human T-inn cells do not differentiate into multiple effector subsets but develop a mixed type 1/type 17 effector potential. Cross-species analysis uncovers species-specific distinctions, including the absence of type 2 T-inn cells in humans, which implies distinct immune regulatory mechanisms across species.
引用
收藏
页数:27
相关论文
共 50 条
  • [31] Evidence for eomesodermin-expressing innate-like CD8+ KIR/NKG2A+ T cells in human adults and cord blood samples
    Jacomet, Florence
    Cayssials, Emilie
    Basbous, Sara
    Levescot, Anais
    Piccirilli, Nathalie
    Desmier, Deborah
    Robin, Aurelie
    Barra, Anne
    Giraud, Christine
    Guilhot, Francois
    Roy, Lydia
    Herbelin, Andre
    Gombert, Jean-Marc
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (07) : 1926 - 1933
  • [32] MHC Class II Restricted Innate-Like Double Negative T Cells Contribute to Optimal Primary and Secondary Immunity to Leishmania major
    Mou, Zhirong
    Liu, Dong
    Okwor, Ifeoma
    Jia, Ping
    Orihara, Kanami
    Uzonna, Jude Ezeh
    PLOS PATHOGENS, 2014, 10 (09)
  • [33] Phenotypic and Functional Changes of Peripheral Ly6C+ T Regulatory Cells Driven by Conventional Effector T Cells
    Lee, Jun Young
    Kim, Juhee
    Yi, Jaeu
    Kim, Daeun
    Kim, Hee-Ok
    Han, Daehee
    Sprent, Jonathan
    Lee, You Jeong
    Surh, Charles D.
    Cho, Jae-Ho
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [34] Phenotypic profiling of human induced regulatory T cells at early differentiation: insights into distinct immunosuppressive potential
    Kattelus, Roosa
    Starskaia, Inna
    Linden, Markus
    Batkulwar, Kedar
    Pietila, Sami
    Moulder, Robert
    Marson, Alexander
    Rasool, Omid
    Suomi, Tomi
    Elo, Laura L.
    Lahesmaa, Riitta
    Buchacher, Tanja
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [35] Unexpected alliance between syndecan-1 and innate-like T cells to protect host from autoimmune effects of interleukin-17
    Jaiswal, Anil Kumar
    Sadasivam, Mohanraj
    Hamad, Abdel Rahim A.
    WORLD JOURNAL OF DIABETES, 2018, 9 (12) : 220 - 225
  • [36] TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models
    Meyran, Deborah
    Zhu, Joe Jiang
    Butler, Jeanne
    Tantalo, Daniela
    MacDonald, Sean
    Nguyen, Thu Ngoc
    Wang, Minyu
    Thio, Niko
    D'Souza, Criselle
    Qin, Vicky Mengfei
    Slaney, Clare
    Harrison, Aaron
    Sek, Kevin
    Petrone, Pasquale
    Thia, Kevin
    Giuffrida, Lauren
    Scott, Andrew M.
    Terry, Rachael L.
    Tran, Ben
    Desai, Jayesh
    Prince, H. Miles
    Harrison, Simon J.
    Beavis, Paul A.
    Kershaw, Michael H.
    Solomon, Ben
    Ekert, Paul G.
    Trapani, Joseph A.
    Darcy, Phillip K.
    Neeson, Paul J.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (690)
  • [37] Early innate responses to pathogens: pattern recognition by unconventional human T-cells
    Liuzzi, Anna Rita
    McLaren, James E.
    Price, David A.
    Eberl, Matthias
    CURRENT OPINION IN IMMUNOLOGY, 2015, 36 : 31 - 37
  • [38] Direct CD137 costimulation of CD8 T cells promotes retention and innate-like function within nascent atherogenic foci
    Xu, Maria M.
    Menoret, Antoine
    Nicholas, Sarah-Anne E.
    Gunther, Sebastian
    Sundberg, Eric J.
    Zhou, Beiyan
    Rodriguez, Annabelle
    Murphy, Patrick A.
    Vella, Anthony T.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2019, 316 (06): : H1480 - H1494
  • [39] Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells
    Chen, Hung-Chang
    Joalland, Noemie
    Bridgeman, John S.
    Alchami, Fouad S.
    Jarry, Ulrich
    Khan, Mohd Wajid A.
    Piggott, Luke
    Shanneik, Yasmin
    Li, Jianqiang
    Herold, Marco J.
    Herrmann, Thomas
    Price, David A.
    Gallimore, Awen M.
    Clarkson, Richard W.
    Scotet, Emmanuel
    Moser, Bernhard
    Eberl, Matthias
    IMMUNOLOGY AND CELL BIOLOGY, 2017, 95 (07) : 620 - 629
  • [40] Innate-like bystander-activated CD38+HLA-DR+CD8+T cells play a pathogenic role in patients with chronic hepatitis C
    Huang, Chien-Hao
    Fan, Jian-He
    Jeng, Wen-Juei
    Chang, Shu-Ting
    Yang, Chan-Keng
    Teng, Wei
    Wu, Tsung-Han
    Hsieh, Yi-Chung
    Chen, Wei-Ting
    Chen, Yi-Cheng
    Sheen, I-Shyan
    Lin, Yung-Chang
    Lin, Chun-Yen
    HEPATOLOGY, 2022, 76 (03) : 803 - 818